Day: September 7, 2023

Los Angeles, CA., Sept. 07, 2023 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions, and systems developer, is pleased to announce that Tim Dunnigan has been appointed to Draganfly’s Advisory Board to help lead Company’s initiatives for the new Pentagon Replicator program. The Pentagon unveiled a new initiative named Replicator, aimed at deploying affordable and autonomous systems in various domains over the next two years to enhance its competitive edge with China. This initiative stands to benefit Draganfly through increased demand, expanded business prospects, potential technology advancements, research and development collaboration, global recognition, and economic growth. “I’m excited to be appointed as an advisor...

Partnership provides access to hospitals in key Asia-Pacific countries Getz Healthcare will make a payment to Beyond Air upon receipt of CE Mark Beyond Air will receive royalty payments based on net sales GARDEN CITY, New York, Sept. 07, 2023 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders and solid tumors (through its affiliate Beyond Cancer, Ltd. (“Beyond Cancer”)), today announced that it has entered into an agreement with Getz Healthcare to commercialize the LungFit PH device in certain countries across the Asia-Pacific region, pending regulatory approvals. “This...

MINNEAPOLIS, Sept. 07, 2023 (GLOBE NEWSWIRE) — Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the following upcoming investor conferences: The Morgan Stanley 21st Annual Global Healthcare Conference, which is being held at the Sheraton New York Times Square in New York, NY from September 11th-13th.Management will participate in investor meetings on Tuesday, September 12th. There will be no formal presentation.The Sidoti Small-Cap Conference, which is being held virtually from September 20th-21st.Management will present on Thursday, September 21st at 10:00 a.m. Eastern Time.A live audio webcast of the presentation will be accessible under the “Events...

CLEVELAND, Sept. 07, 2023 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that members of its management team will participate in upcoming investor conferences in September 2023:A company presentation at the H.C. Wainwright Annual Global Investment Conference on Wednesday, September 13, 2023 at 10:00 a.m. ET. A fireside chat at the Cantor Global Healthcare Conference on Tuesday, September 26, 2023 at 2:10 p.m. ET. A fireside chat at the Jefferies Cell & Genetic Medicine Summit on Wednesday, September 27, 2023 at 9:30 a.m. ET.A live webcast of the presentation and fireside chats can be accessed on the Investors section of the Abeona website under “Events” at https://investors.abeonatherapeutics.com/events, where a replay of the events will also be available for a limited time. About...

VANCOUVER, British Columbia, Sept. 07, 2023 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian psychedelics drug research and formulation company, proudly announced today that Health Canada has approved an amendment to the Company’s Dealer’s Licence. The amendment empowers Optimi to embark on the formal supply journey for Canada’s Special Access Program (SAP), operating within the provisions of the Controlled Drugs and Substances Act and its Regulations. Under rigorous licensing regulations, Canadian entities engaged in the cultivation and formulation of psychedelic substances and who wish to supply Canada’s Special Access Program must secure approval from Health Canada’s Office of Controlled Substances Division. Optimi has successfully navigated this regulatory landscape, surmounting...

WARMINSTER, Pa., Sept. 07, 2023 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced that the Arbutus management team will participate in and host one-on-one meetings at the following two upcoming investor conferences: H.C. Wainwright 25th Annual Global Investment Conference: Formal Presentation on September 12, 2023 at 3:30 pm ET Baird’s 2023 Global Healthcare Conference: Fireside Chat on September 13, 2023 at 7:55 am ET To access the live webcast of the presentations please visit: https://investor.arbutusbio.com/events-presentations. An archived replay of the webcast will be available on the Arbutus website for a limited time after the event. About...

Tailings Dam Foundation at 78% CompletionFigure 1:Overview of TMF Construction, September 2, 2023Figure 2:“Zone 6” Rockfill placed on prepared and approved foundation for the TMF Phase 1 Dam, looking northwest. On the upstream side (top left of photograph) shows the prepared foundation without any fill material placement, August 29, 2023Figure 3:Progress of “Zone 6” rockfill placement on prepared and approved foundation for the TMF Main Dam. Top: progress of approved Zone 6 placement as of September 3, 2023. Bottom: TMF Configurations for Phase 1, 2025-2026 (Bottom Left) and Ultimate Design, after Phase 6, 2032-2034 (Bottom Right). Bottom images from NI 43-101 Technical Report “Valentine Gold Project, NI 43-101 Technical Report and Feasibility Study” effective November 30, 2022.TORONTO, Sept. 07, 2023 (GLOBE...

SAFETY HARBOR, Florida, Sept. 07, 2023 (GLOBE NEWSWIRE) — Eightco Holdings Inc. (NASDAQ: OCTO) (“Eightco” or the “Company”) announced today it will be presenting at the H.C. Wainwright 25th Annual Global Investment Conference, held September 11-13, 2023, at the Lotte New York Palace Hotel in New York City. The Company’s leadership team, including CEO Brian McFadden and CFO Brett Vroman, along with other key executives, will be in attendance during the presentation and will be available for one-on-one meetings throughout the conference. This conference serves as an excellent platform for Eightco to engage with the investor community and discuss various facets of our business. We look forward to sharing insights into our recent achievements, ongoing developments, and our strategic vision for the future. Brian McFadden, CEO of Eightco...

OSB GROUP PLC7 September 2023 LEI: 213800ZBKL9BHSL2K459 OSB GROUP PLC£3 BILLION EURO MEDIUM TERM NOTE PROGRAMMEPUBLICATION OF FINAL TERMS – SERIES 2023-2 The following final terms (the “Final Terms”) are available for viewing: Issue of GBP 300,000,000 Fixed Rate Resetting Notes due 7 September 2028 (ISINXS2642668821) (Series 2023-2) (the “Notes”) under the £3 billion Euro Medium Term Note programme of OSB GROUP PLC (the “Programme”). Please read the disclaimer below “Disclaimer – Intended Addressees” before attempting to access this service, as your right to do so is conditional upon complying with the requirements set out below. To view the Final Terms, paste the following URL into the address bar of your browser: https://www.osb.co.uk/investors/debt-investors/emtn-programme/ A copy of the Final Terms has been submitted...

TORONTO, Sept. 07, 2023 (GLOBE NEWSWIRE) — Flow Capital Corp. (TSXV:FW) (“Flow Capital” and “Company”), a leading provider of flexible growth capital and alternative debt solutions, is pleased to announce that it has completed a second tranche of its previously disclosed non-convertible loan transaction in the principal amount of C$3.015 million (the “Loans”). The Loans will be evidenced by unsecured, non-convertible debentures (the “Debentures”) issued by the Company to the Lenders pursuant to the terms of a debenture indenture entered between the Company and Olympia Trust Company, as debenture trustee. The Company closed an initial tranche of loans on August 1, 2023 with lenders advancing an aggregate amount of C$17.9 million. Additional details regarding the terms of the Loans can be found in the Company’s press release...